Realistic weight loss expectations require understanding your unique metabolic baseline, genetic predispositions, and lifestyle factorsnot just population averages
and while they kinda sound similar, theyre not exactly the same, and your experience on each one might be different too
As a triple-agonist compound simultaneously engaging GLP-1, GIP, and glucagon receptors, retatrutide requires sophisticated dosing strategies that account for its unique pharmacokinetic profile, receptor occupancy dynamics, and dose-dependent adverse event spectrum
However, none of the trial investigators reported serious side effects due to the use of LC
Baumann's conclusion: " sufficient evidence to establish a causal link between RP and skin cancer has not been produced